101 related articles for article (PubMed ID: 17500197)
1. [The role of the ovarian steroid aromatase in pathogenesis of reproductive cycles disorders].
Tarasenko LV; Reznikov OH
Fiziol Zh (1994); 2007; 53(1):11-5. PubMed ID: 17500197
[TBL] [Abstract][Full Text] [Related]
2. Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary.
Ortega I; Sokalska A; Villanueva JA; Cress AB; Wong DH; Stener-Victorin E; Stanley SD; Duleba AJ
Fertil Steril; 2013 Mar; 99(3):889-96. PubMed ID: 23200686
[TBL] [Abstract][Full Text] [Related]
3. Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat.
Sinha S; Kaseta J; Santner SJ; Demers LM; Bremmer WJ; Santen RJ
Breast Cancer Res Treat; 1998 Mar; 48(1):45-51. PubMed ID: 9541188
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors: A new approach for controlling ovarian function in cattle.
Yapura MJ; Zwiefelhofer EM; Pierson RA; Adams GP
Theriogenology; 2018 May; 112():18-25. PubMed ID: 28911882
[TBL] [Abstract][Full Text] [Related]
5. A bovine model for examining the effects of an aromatase inhibitor on ovarian function in women.
Yapura J; Mapletoft RJ; Pierson R; Singh J; Naile J; Giesy JP; Adams GP
Fertil Steril; 2011 Aug; 96(2):434-438.e3. PubMed ID: 21696721
[TBL] [Abstract][Full Text] [Related]
6. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
7. Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle.
Yapura MJ; Mapletoft RJ; Singh J; Pierson R; Naile J; Giesy JP; Chang H; Higley E; Hecker M; Adams GP
Reprod Fertil Dev; 2012; 24(4):631-40. PubMed ID: 22541551
[TBL] [Abstract][Full Text] [Related]
8. Effects of electro-acupuncture on ovarian P450arom, P450c17α and mRNA expression induced by letrozole in PCOS rats.
Sun J; Jin C; Wu H; Zhao J; Cui Y; Liu H; Wu L; Shi Y; Zhu B
PLoS One; 2013; 8(11):e79382. PubMed ID: 24260211
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary co-administration of sodium selenite on sodium arsenite-induced ovarian and uterine disorders in mature albino rats.
Chattopadhyay S; Pal Ghosh S; Ghosh D; Debnath J
Toxicol Sci; 2003 Oct; 75(2):412-22. PubMed ID: 12883085
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
11. The effects of metformin and letrozole on endometrium and ovary in a rat model.
Oner G; Ozcelik B; Ozgun MT; Ozturk F
Gynecol Endocrinol; 2011 Dec; 27(12):1084-6. PubMed ID: 21770833
[TBL] [Abstract][Full Text] [Related]
12. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
Aydin M; Yilmaz B; Alcin E; Nedzvetsky VS; Sahin Z; Tuzcu M
Neuroscience; 2008 Jan; 151(1):186-94. PubMed ID: 18061360
[TBL] [Abstract][Full Text] [Related]
13. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
Maliqueo M; Sun M; Johansson J; Benrick A; Labrie F; Svensson H; Lönn M; Duleba AJ; Stener-Victorin E
Endocrinology; 2013 Jan; 154(1):434-45. PubMed ID: 23183180
[TBL] [Abstract][Full Text] [Related]
14. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.
Zurvarra FM; Salvetti NR; Mason JI; Velazquez MM; Alfaro NS; Ortega HH
Reprod Fertil Dev; 2009; 21(7):827-39. PubMed ID: 19698287
[TBL] [Abstract][Full Text] [Related]
15. Sex reversal and aromatase in the European pond turtle: treatment with letrozole after the thermosensitive period for sex determination.
Belaid B; Richard-Mercier N; Pieau C; Dorizzi M
J Exp Zool; 2001 Sep; 290(5):490-7. PubMed ID: 11555856
[TBL] [Abstract][Full Text] [Related]
16. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
17. Collaborative work on evaluation of ovarian toxicity. 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats.
Shirai M; Sakurai K; Saitoh W; Matsuyama T; Teranishi M; Furukawa T; Sanbuissho A; Manabe S
J Toxicol Sci; 2009; 34 Suppl 1():SP91-9. PubMed ID: 19265294
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.
Langoi D; Pavone ME; Gurates B; Chai D; Fazleabas A; Bulun SE
Fertil Steril; 2013 Mar; 99(3):656-662.e3. PubMed ID: 23257603
[TBL] [Abstract][Full Text] [Related]
20. The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice.
Bondi CD; Alonso-Gonzalez C; Clafshenkel WP; Kotlarczyk MP; Dodda BR; Sanchez-Barcelo E; Davis VL; Witt-Enderby PA
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():80-5. PubMed ID: 24373455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
